trimethoprim has been researched along with Choroiditis in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Choroiditis: Inflammation of the choroid.
Excerpt | Relevance | Reference |
---|---|---|
"Pneumocystis carinii pneumonia is a major cause of morbidity and mortality in patients with the acquired immunodeficiency syndrome." | 5.28 | Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. ( Chong, LP; Dugel, PU; Forster, DJ; Frangieh, GT; Rao, NA; Sattler, F, 1990) |
"Pneumocystis carinii pneumonia is a major cause of morbidity and mortality in patients with the acquired immunodeficiency syndrome." | 1.28 | Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy. ( Chong, LP; Dugel, PU; Forster, DJ; Frangieh, GT; Rao, NA; Sattler, F, 1990) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Patey, O | 1 |
Salvanet, A | 1 |
Serrhini, A | 1 |
Lafaix, C | 1 |
Dugel, PU | 1 |
Rao, NA | 1 |
Forster, DJ | 1 |
Chong, LP | 1 |
Frangieh, GT | 1 |
Sattler, F | 1 |
2 other studies available for trimethoprim and Choroiditis
Article | Year |
---|---|
Pneumocystis carinii choroidopathy in AIDS patients.
Topics: Adult; AIDS-Related Opportunistic Infections; Angiography; Choroiditis; Humans; Male; Pneumocystis I | 1993 |
Pneumocystis carinii choroiditis after long-term aerosolized pentamidine therapy.
Topics: Adult; Aerosols; Choroiditis; Drug Administration Schedule; Fluorescein Angiography; Follow-Up Studi | 1990 |